[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

US Pharmaceuticals and Biotechnology Industry Comparative Analysis and Companies Ranking

September 2024 | 50 pages | ID: U3CD58DCA4EEN
BAC Reports

US$ 1,000.00

Email Delivery - PDF (on default)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
  • The report analyses Pharmaceuticals and Biotechnology Industry in United States. It covers general statistics, including industry volumes by sales and income, and industry dynamics within the recent period. The description of industry structure by company is included as well, establishing extent of market concentration and evaluating companies’ market shares. Analysis includes detailed information about the internal and external factors that affect Pharmaceuticals and Biotechnology Industry in United States.
  • The report provides detailed Pharmaceuticals and Biotechnology Industry comparative analysis with interrelated data on major companies. The areas under consideration are as follows:
    - company strategic position in the industry
    - profitability and margin analysis
    - assets turnover and credit ratios reviews
    - long-term solvency indicators
    - growth trends comparison
  • The report also presents company rankings by size, value, profit margin and growth history, thus giving a full picture of each company mentioned.
  • The report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases. Annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of the industry.

RESEARCH METHODOLOGY

DISCLAIMER

1. CORPORATE ANALYSIS OF UNITED STATES PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY

1.1. Key Facts
1.2. Industry Volume
1.3. Industry Dynamics

2. UNITED STATES PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY COMPARATIVE ANALYSIS

2.1. Stock Analysis
2.2. Current Market State
2.3. Comparative Financial Analysis
2.3.1. Profitability Analysis
2.3.2. Margin Analysis
2.3.3. Assets Turnover Analysis
2.3.4. Credit Ratios
2.3.5. Long-Term Solvency Analysis
  2.3.6. Growth Over Prior Year Trends

3. UNITED STATES PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY RANKINGS

3.1. Company Rankings by Size
3.2. Company Rankings by Value
3.3. Company Rankings by Profit Margins
3.4. Company Rankings by Growth History

4. UNITED STATES PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY NEWS

4.1. News & PR Activity Analysis
4.2. United States Pharmaceuticals and Biotechnology Industry Significant Developments
4.3. Marketing News
4.4. Corporate Events

5. INDUSTRY EXPERTS FORECAST AND OPINIONS

APPENDIX: RATIO DEFINITIONS


The above Industry Comparative Analysis is a half-ready report.
 It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 3-5 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 40,000 different companies available but it is impossible to have all reports updated immediately. That is why it takes 3-5 days to update a report after an order is received.

LIST OF TABLES 

Table 1. The list of Companies Included in the Research
Table 2. United States Pharmaceuticals and Biotechnology Industry Snapshot
Table 3. United States Pharmaceuticals and Biotechnology Industry Annual Revenues, Gross Profit and Net Income
Table 4. United States Pharmaceuticals and Biotechnology Industry Quarterly Revenues, Gross Profit and Net Income
Table 5. United States Pharmaceuticals and Biotechnology Industry Annual Growth Rates, %
Table 6. United States Pharmaceuticals and Biotechnology Industry Quarterly Growth Rates, %
Table 7. United States Pharmaceuticals and Biotechnology Industry Companies Stock Performance
Table 8. Companies Market Shares, %
Table 9. United States Pharmaceuticals and Biotechnology Industry Companies Profitability Ratios
Table 10. United States Pharmaceuticals and Biotechnology Industry Companies Margin Analysis Ratios
Table 11. United States Pharmaceuticals and Biotechnology Industry Companies Assets Turnover Ratios
Table 12. United States Pharmaceuticals and Biotechnology Industry Companies Credit Ratios
Table 13. United States Pharmaceuticals and Biotechnology Industry Companies Long-Term Solvency Ratios
Table 14. United States Pharmaceuticals and Biotechnology Industry Companies Growth Over Prior Year Ratios
Table 15. United States Pharmaceuticals and Biotechnology Industry Leaders by Market Capitalization
Table 16. United States Pharmaceuticals and Biotechnology Industry Leaders by Revenues
Table 17. United States Pharmaceuticals and Biotechnology Industry Leaders by Net Income
Table 18. United States Pharmaceuticals and Biotechnology Industry Leaders by Employees
Table 19. United States Pharmaceuticals and Biotechnology Industry Leaders by Price per Earnings
Table 20. United States Pharmaceuticals and Biotechnology Industry Leaders by Price to Sales
Table 21. United States Pharmaceuticals and Biotechnology Industry Leaders by Price to Book
Table 22. United States Pharmaceuticals and Biotechnology Industry Leaders by Price to Cash Flow
Table 23. United States Pharmaceuticals and Biotechnology Industry Leaders by Profit Margin
Table 24. United States Pharmaceuticals and Biotechnology Industry Leaders by Operating Margin
Table 25. United States Pharmaceuticals and Biotechnology Industry Leaders by Return on Assets
Table 26. United States Pharmaceuticals and Biotechnology Industry Leaders by Earnings per Share
Table 27. United States Pharmaceuticals and Biotechnology Industry Leaders by Revenue Growth Rate


LIST OF FIGURES

Figure 1. United States Pharmaceuticals and Biotechnology Industry Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Figure 2. Industry Concentration, %
Figure 3. United States Pharmaceuticals and Biotechnology Industry Dynamics, 4 Year Trends
Figure 4. United States Pharmaceuticals and Biotechnology Industry Dynamics, Last 4 Quarter Trends
Figure 5. United States Pharmaceuticals and Biotechnology Industry 1-year Stock Chart
Figure 6. United States Pharmaceuticals and Biotechnology Industry vs. Main Indexes 1-year Stock Chart
Figure 7. United States Pharmaceuticals and Biotechnology Industry Structure by Companies, %
Figure 8. Growth-Share Matrix: Companies Strategic Position in United States Pharmaceuticals and Biotechnology Industry (Recent Year Trends)
Figure 9. Growth-Share Matrix: Companies Strategic Position in United States Pharmaceuticals and Biotechnology Industry (Recent Quarter Trends)
Figure 10. Return on Assets Chart by Companies
Figure 11. Return on Equity Chart by Companies
Figure 12. Profitability Peer Analysis
Figure 13. Profit Margin Chart by Companies
Figure 14. Operating Margin Chart by Companies
Figure 15. Margin Peer Analysis
Figure 16. Assets Turnover Peer Analysis
Figure 17. Current Ratio Chart by Companies in
Figure 18. Growth Over Prior Year Peer Analysis
Figure 19. United States Pharmaceuticals and Biotechnology Industry Article Density Chart


THE FOLLOWING COMPANIES ARE INCLUDED IN THE RESEARCH:

Orexigen Therapeutics, Inc.Osiris Therapeutics, Inc.Osteologix, Inc.
Oxigene Inc.OXIS International Inc.Oxygen Biotherapeutics, Inc.
Pacific Biomarkers, IncPacific Biosciences of California, Inc.Pacifichealth Laboratories Inc.
Pain Therapeutics Inc.Palatin Technologies Inc.Par Pharmaceutical Companies Inc.
Parexel International Corp.PDL BioPharma, Inc.Peregrine Pharmaceuticals Inc.
PerkinElmer Inc.Pernix Therapeutics Holdings, Inc.Perrigo Co.
Pfizer Inc.Pharma-Bio Serv, Inc.Pharmaceutical Product Development Inc.
Pharmacyclics Inc.Pharmasset, Inc.PharmAthene, Inc.
Pharmos Corp.PhytoMedical Technologies Inc.PolyMedix, Inc.
Poniard Pharmaceuticals, Inc.Power 3 Medical Products Inc.PowerVerde, Inc.
POZEN, Inc.Precision Optics Corp. Inc.Pressure BioSciences, Inc.
Pro-Pharmaceuticals Inc.Progenics Pharmaceuticals Inc.ProPhase Labs, Inc.
Protalex Inc.Proteo Inc.Proteonomix, Inc.
Provectus Pharmaceuticals, Inc.pSivida Corp.Pulmo BioTech Inc.
Puramed Bioscience IncPure BioscienceRealm Therapeutics Plc
Questcor Pharmaceuticals, Inc.Quick-Med Technologies Inc.Radient Pharmaceuticals Corporation
Raptor Pharmaceuticals Corp.Redpoint Bio CorporationReflect Scientific, Inc.
Regeneron Pharmaceuticals, Inc.Regenerx Biopharmaceuticals Inc.Regenicin, Inc.
Repligen CorporationRepros Therapeutics Inc.Response Genetics, Inc
Rexahn Pharmaceuticals, Inc.Rigel Pharmaceuticals, Inc.RXi Pharmaceuticals Corporation
Salix Pharmaceuticals Ltd.Sangamo Biosciences Inc.Sanguine Corp.
Santarus Inc.Savient Pharmaceuticals, Inc.SciClone Pharmaceuticals, Inc.
SCOLR Pharma Inc.Seattle Genetics Inc.Senesco Technologies Inc.
SensiVida Medical Technologies, Inc.Sequenom Inc.SeraCare Life Sciences, Inc.
SIGA Technologies, Inc.Soligenix, Inc.Somaxon Pharmaceuticals, Inc.
Sorrento Therapeutics, Inc.Spectrum Pharmaceuticals, Inc.Stellar Biotechnologies, Inc.
Stem Cell Authority, Ltd.StemCells Inc.Strategic Diagnostics Inc.
Sucampo Pharmaceuticals, Inc.Sunesis Pharmaceuticals Inc.SuperGen Inc.
Symbollon Pharmaceuticals Inc.Synergy Pharmaceuticals, Inc.Synta Pharmaceuticals Corp.
SyntheMed Inc.Talon Therapeutics, Inc.Tamir Biotechnology, Inc.
and 359 companies more



More Publications